Efficacy and Safety of VB10.16 Alone or in Combination With Atezolizumab in Patients With Advanced Cervical Cancer.
Nykode Therapeutics ASA
Nykode Therapeutics ASA
University of Arkansas
AdventHealth
University of Chicago
Queen Mary University of London
Massachusetts General Hospital
Targovax ASA
CytoDyn, Inc.
Federation Francophone de Cancerologie Digestive
Hoosier Cancer Research Network
Actuate Therapeutics Inc.
Ohio State University Comprehensive Cancer Center
University of Colorado, Denver
Sun Yat-sen University
Eli Lilly and Company
Grupo Español Multidisciplinar de Melanoma
Institut de Cancérologie de la Loire
Military Institute od Medicine National Research Institute
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
University of Kentucky
University of Kansas Medical Center
GlaxoSmithKline
The University of Texas Health Science Center, Houston
The Methodist Hospital Research Institute
Barts & The London NHS Trust
NYU Langone Health
Hoffmann-La Roche
Galectin Therapeutics Inc.
National Institutes of Health Clinical Center (CC)
University of California, Davis
European Organisation for Research and Treatment of Cancer - EORTC
Columbia University
European Organisation for Research and Treatment of Cancer - EORTC
AHS Cancer Control Alberta
SCRI Development Innovations, LLC
Berufsverband Niedergelassener Gynäkologischer Onkologen in Deutschland e.V.
ImmunoGen, Inc.
AmpliMed Corporation
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Comprehensive Cancer Centers of Nevada
Barretos Cancer Hospital
Cornerstone Pharmaceuticals
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
SWOG Cancer Research Network
M.D. Anderson Cancer Center
National Cancer Center, Korea
H. Lee Moffitt Cancer Center and Research Institute